Croatia leads global antidepressant medicine sales with $47.1 PPP per capita, followed by Canada at $32.9 and Iceland at $23.3. Greece and Chile see significant sales levels at $17 and $12.4, respectively. Slovenia, Luxembourg, Sweden, Estonia, Denmark, and New Zealand lag behind. Notably, trends between 2023 and 2024 show substantial year-on-year variations: Iceland and Chile experienced impressive growth, while Greece, Luxembourg, and Denmark saw declines. The last five years indicate robust Compound Annual Growth Rates (CAGRs) for key players like Estonia and Chile.
Future trends to watch include an increase in mental health awareness driving higher sales in developing markets, and advancements in pharmaceutical technology leading to new, potentially more expensive antidepressants, further influencing per capita spending.
Top countries in Antidepressant Medicine Sales by Country
| # | 10 Countries | US Dollars PPP Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Croatia | 47.1 | 2023 | +0.21% | +1.42% | View data |
| 2 | 2 Canada | 32.9 | 2023 | -0.3% | +2.77% | View data |
| 3 | 3 Iceland | 23.3 | 2023 | +3.1% | +6.26% | View data |
| 4 | 4 Greece | 17 | 2023 | 0% | -0.58% | View data |
| 5 | 5 Chile | 12.4 | 2023 | +3.33% | +7.34% | View data |
| 6 | 6 Slovenia | 10.3 | 2023 | -0.96% | +1.85% | View data |
| 7 | 7 Luxembourg | 8.3 | 2023 | -6.74% | -5.3% | View data |
| 8 | 8 Sweden | 8.1 | 2023 | -2.41% | +0.25% | View data |
| 9 | 9 Estonia | 7.1 | 2023 | +4.41% | +6.84% | View data |
| 10 | 10 Denmark | 4.2 | 2023 | -8.7% | -5.25% | View data |
